(Q34723833)

English

Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur (English)

1 reference

Europe PubMed Central

4 August 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

Theodorus H Van der Kwast

object named as

Theodorus van der Kwast

7

0 references

Rodolfo Montironi

8

object named as

Rodolfo Montironi

1 reference

Europe PubMed Central

4 August 2017

Marina Scarpelli

6

object named as

Marina Scarpelli

1 reference

Europe PubMed Central

4 August 2017

5

object named as

Liang Cheng

1 reference

Europe PubMed Central

4 August 2017

Antonio Lopez-Beltran

4

object named as

Antonio Lopez-Beltran

1 reference

Europe PubMed Central

4 August 2017

Roberta Mazzucchelli

3

object named as

Roberta Mazzucchelli

1 reference

Europe PubMed Central

4 August 2017

Francesca Barbisan

1

object named as

Francesca Barbisan

1 reference

Europe PubMed Central

4 August 2017

Alfredo Santinelli

2

object named as

Alfredo Santinelli

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

1 February 2008

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

112

1 reference

Europe PubMed Central

4 August 2017

636-644

1 reference

Europe PubMed Central

4 August 2017

3

1 reference

Europe PubMed Central

4 August 2017

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

21 January 2018

Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of the urothelial tumors of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular evolution of multiple recurrent cancers of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

FGFR activation in skeletal disorders: too much of a good thing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic alterations in urothelial bladder carcinoma: an updated review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23212

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23212

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34723833&oldid=2121877673"